116 related articles for article (PubMed ID: 6339850)
21. Immunoglobulin concentration in serum and seminal fluid from men with and without sperm-agglutinating antibodies.
Friberg J
Am J Obstet Gynecol; 1980 Mar; 136(5):671-5. PubMed ID: 7355947
[TBL] [Abstract][Full Text] [Related]
22. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
Stefano S; Kerman R; Abbate J
AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
[TBL] [Abstract][Full Text] [Related]
23. Serum immunoglobulins in healthy children and adults. Levels of the five classes, expressed in international units per millilitre.
Zegers BJ; Stoop JW; Reerink-Brongers EE; Sander PC; Aalberse RC; Ballieux RE
Clin Chim Acta; 1975 Dec; 65(3):319-29. PubMed ID: 1204222
[TBL] [Abstract][Full Text] [Related]
24. Serum IgD and IgE in rheumatoid arthritis.
Marcolongo R; Marsili C
Z Immunitatsforsch Exp Klin Immunol; 1975 Feb; 148(4):285-90. PubMed ID: 126543
[TBL] [Abstract][Full Text] [Related]
25. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
Browder JP; Chretien PB
Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
[No Abstract] [Full Text] [Related]
26. Immunoglobulin characterization of human pancreatic fluid.
Brasher GW; Dyck WP; Hall FF; Spiekerman AM
Am J Dig Dis; 1975 May; 20(5):454-9. PubMed ID: 805530
[TBL] [Abstract][Full Text] [Related]
27. Abnormal serum immunoglobulin levels in Down's syndrome patients.
Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
[TBL] [Abstract][Full Text] [Related]
28. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
[TBL] [Abstract][Full Text] [Related]
29. Cellular immune profile and T-lymphocyte blocking factors in cancer of the head and neck and their prognostic significance.
Sinha R; Gupta SC; Naithani YP
Indian J Cancer; 1985 Mar; 22(1):8-16. PubMed ID: 3879757
[No Abstract] [Full Text] [Related]
30. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
31. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
33. Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
Chang PH; Yeh KY; Wang CH; Chen EY; Yang SW; Huang JS; Chou WC; Hsieh JC
Head Neck; 2017 Oct; 39(10):1990-1996. PubMed ID: 28688124
[TBL] [Abstract][Full Text] [Related]
34. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
36. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck.
Palme CE; MacKay SG; Kalnins I; Morgan GJ; Veness MJ
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):103-6. PubMed ID: 17413411
[TBL] [Abstract][Full Text] [Related]
37. [Illness stage and IgA-anti-Fab/F(ab')2 autoantibody activity in serum of patients with malignant head-neck tumors].
Lorenz KJ; Süsal C; Opelz G; Maier H
Laryngorhinootologie; 1996 Dec; 75(12):764-8. PubMed ID: 9081283
[TBL] [Abstract][Full Text] [Related]
38. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
39. Cellular immunity in patients with epidermoid cancer of the head and neck.
Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
[TBL] [Abstract][Full Text] [Related]
40. T-cell deficiency in patients with squamous cell cancer of the head and neck.
Wanebo HJ; Jun MY; Strong EW; Oettgen H
Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
